[en] Background: Gamma-hydroxybutyrate (GHB) may be an interesting hypnotic agent in burn patients because of its good respiratory or hemodynamic tolerance. However, its clinical and electroencephalographic (EEG) sedative effects are not yet described in children. The aim of this prospective and randomized study was to assess clinical and EEG effects of increasing intravenous (IV) doses of GHB in burn children requiring sedation for burn wound cares. Methods: Thirty six children hospitalized in a burn care unit were included and randomly assigned into three groups (G) according to the single IV dose of GHB they received before burn wound care: 10 mg·kg(-1) in G10, 25 mg·kg(-1) in G25, or 50 mg·kg(-1) in G50. All patients received oral premedication (morphine and hydroxyzine) 30 min before GHB injection. Respiratory rate, heart rate, pulse oximetry, and bispectral index (BIS) were continuously monitored. Depth of sedation was clinically assessed using Observer's Assessment of Alertness and Sedation (OAAS) Score, every 2 min until recovery (i.e., OAAS = 4). Results: Median age was 17.5 [12-34] months. Whatever the dose, BIS decreased after IV GHB. Nadir value of BIS was significantly lower in G25 and G50 than in G10, as was for OAAS score. Nadir values were reached after same delays in G25 and G50. Duration of sedation was dose-dependant. Conclusion: Bispectral index decreased after GHB injection and was correlated with OAAS score. Deep sedation can be safely achieved with IV doses of 25 or 50 mg·kg(-1) , but the last dose was associated with prolonged duration of clinical sedation.
Laborit H, Buchard F, Laborit G, et al. [Use of sodium 4-hydroxybutyrate in anesthesia and resuscitation]. Agressologie 1960; 1: 549-560.
Laborit H, Jouany JM, Gerard J, et al. [Generalities concerning the experimental study and clinical use of gamma hydroxybutyrate of Na]. Agressologie 1960; 1: 397-406.
Wedin GP, Hornfeldt CS, Ylitalo LM,. The clinical development of gamma-hydroxybutyrate (GHB). Curr Drug Saf 2006; 1: 99-106.
Kleinschmidt S, Mertzlufft F,. [Gamma-hydroxybutyric acid-significance for anesthesia and intensive care medicine?] Anasthesiol Intensivmed Notfallmed Schmerzther 1995; 30: 393-402.
Entholzner E, Mielke L, Pichlmeier R, et al. [EEG changes during sedation with gamma-hydroxybutyric acid]. Anaesthesist 1995; 44: 345-350.
Poschl J, Kolker S, Bast T, et al. Gamma-hydroxybutyric acid sedation in neonates and children undergoing MR imaging. Klin Padiatr 2007; 219: 217-219.
Kleinschmidt S, Grundmann U, Knocke T, et al. Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function. Eur J Anaesthesiol 1998; 15: 559-564.
Soltesz S, Silomon M, Biedler A, et al. [Gamma-hydroxybutyric acid-ethanolamide (LK 544). The suitability of LK 544 for sedation of patients in intensive care in comparison with midazolam]. Anaesthesist 2001; 50: 323-328.
Dahaba AA,. Different conditions that could result in the bispectral index indicating an incorrect hypnotic state. Anesth Analg 2005; 101: 765-773.
Johansen JW,. Update on bispectral index monitoring. Best Pract Res Clin Anaesthesiol 2006; 20: 81-99.
Johansen JW, Sebel PS,. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000; 93: 1336-1344.
Potter D,. Permutation tests of correlation with repeated measurements. 2011; Available at:. Accessed 2 September, 2011.
Mamelak M,. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 1989; 13: 187-198.
Series F, Series I, Cormier Y,. Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea. Am Rev Respir Dis 1992; 145: 1378-1383.
Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. J Clin Invest 1997; 100: 745-753.
Okun MS, Boothby LA, Bartfield RB, et al. GHB: an important pharmacologic and clinical update. J Pharm Pharm Sci 2001; 4: 167-175.
Boveroux P, Vanhaudenhuyse A, Bruno MA, et al. Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology 2010; 113: 1038-1053.
Watson BD, Kane-Gill SL,. Sedation assessment in critically ill adults: 2001-2004 update. Ann Pharmacother 2004; 38: 1898-1906.
Iselin-Chaves IA, Flaishon R, Sebel PS, et al. The effect of the interaction of propofol and alfentanil on recall, loss of consciousness, and the Bispectral Index. Anesth Analg 1998; 87: 949-955.
Kearse LA Jr, Rosow C, Zaslavsky A, et al. Bispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis. Anesthesiology 1998; 88: 25-34.
Liu J, Singh H, White PF,. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997; 84: 185-189.
Blumenfeld M, Suntay RG, Harmel MH,. Sodium gamma-hydroxybutyric acid: a new anesthetic adjuvant. Anesth Analg 1962; 41: 721.
Blanchet B, Jullien V, Vinsonneau C, et al. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet 2008; 47: 635-654.
Borgen LA, Okerholm RA, Lai A, et al. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 2004; 44: 253-257.
Constant I,. BIS use in pediatric anesthesia: where are we? Can J Anaesth 2004; 51: 411-416.
Degoute CS, Macabeo C, Dubreuil C, et al. EEG bispectral index and hypnotic component of anaesthesia induced by sevoflurane: comparison between children and adults. Br J Anaesth 2001; 86: 209-212.
